Effect of estrogen receptor-alpha (ESR1) gene polymorphism on high density lipoprotein levels in response to hormone replacement therapy

Studies have shown that estrogen replacement therapy and estrogen plus progestin replacement therapy alter serum levels of total, LDL and HDL cholesterol levels. However, HDL cholesterol levels in women vary considerably in response to hormone replacement therapy (HRT). A significant portion of the...

Full description

Bibliographic Details
Main Authors: N.C. Nogueira-de-Souza, I.D.C. Guerreiro da Silva, C.V. de Carvalho, A. Pulchinelli, M.A. Haidar, E.C. Baracat, A.M. Massad-Costa
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 2009-12-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2009001200003
_version_ 1828520370422939648
author N.C. Nogueira-de-Souza
I.D.C. Guerreiro da Silva
C.V. de Carvalho
A. Pulchinelli
M.A. Haidar
E.C. Baracat
A.M. Massad-Costa
author_facet N.C. Nogueira-de-Souza
I.D.C. Guerreiro da Silva
C.V. de Carvalho
A. Pulchinelli
M.A. Haidar
E.C. Baracat
A.M. Massad-Costa
author_sort N.C. Nogueira-de-Souza
collection DOAJ
description Studies have shown that estrogen replacement therapy and estrogen plus progestin replacement therapy alter serum levels of total, LDL and HDL cholesterol levels. However, HDL cholesterol levels in women vary considerably in response to hormone replacement therapy (HRT). A significant portion of the variability of these levels has been attributed to genetic factors. Therefore, we investigated the influence of estrogen receptor-alpha (ESR1) gene polymorphisms on HDL levels in response to postmenopausal HRT. We performed a prospective cohort study on 54 postmenopausal women who had not used HRT before the study and had no significant general medical illness. HRT consisted of conjugated equine estrogen and medroxyprogesterone acetate continuously for 1 year. The lipoprotein levels were measured from blood samples taken before the start of therapy and after 1 year of HRT. ESR1 polymorphism (MspI C>T, HaeIII C>T, PvuII C>T, and XbaI A>G) frequencies were assayed by restriction fragment length polymorphism. A general linear model was used to describe the relationships between HDL levels and genotypes after adjusting for age. A significant increase in HDL levels was observed after HRT (P = 0.029). Women with the ESR1 PvuII TT genotype showed a statistically significant increase in HDL levels after HRT (P = 0.032). No association was found between other ESR1 polymorphisms and HDL levels. According to our results, the ESR1 PvuII TT genotype was associated with increased levels of HDL after 1 year of HRT.
first_indexed 2024-12-11T19:29:53Z
format Article
id doaj.art-8ab49ac2c70345729684c62a84378bdc
institution Directory Open Access Journal
issn 0100-879X
1414-431X
language English
last_indexed 2024-12-11T19:29:53Z
publishDate 2009-12-01
publisher Associação Brasileira de Divulgação Científica
record_format Article
series Brazilian Journal of Medical and Biological Research
spelling doaj.art-8ab49ac2c70345729684c62a84378bdc2022-12-22T00:53:18ZengAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research0100-879X1414-431X2009-12-0142121138114210.1590/S0100-879X2009001200003Effect of estrogen receptor-alpha (ESR1) gene polymorphism on high density lipoprotein levels in response to hormone replacement therapyN.C. Nogueira-de-SouzaI.D.C. Guerreiro da SilvaC.V. de CarvalhoA. PulchinelliM.A. HaidarE.C. BaracatA.M. Massad-CostaStudies have shown that estrogen replacement therapy and estrogen plus progestin replacement therapy alter serum levels of total, LDL and HDL cholesterol levels. However, HDL cholesterol levels in women vary considerably in response to hormone replacement therapy (HRT). A significant portion of the variability of these levels has been attributed to genetic factors. Therefore, we investigated the influence of estrogen receptor-alpha (ESR1) gene polymorphisms on HDL levels in response to postmenopausal HRT. We performed a prospective cohort study on 54 postmenopausal women who had not used HRT before the study and had no significant general medical illness. HRT consisted of conjugated equine estrogen and medroxyprogesterone acetate continuously for 1 year. The lipoprotein levels were measured from blood samples taken before the start of therapy and after 1 year of HRT. ESR1 polymorphism (MspI C>T, HaeIII C>T, PvuII C>T, and XbaI A>G) frequencies were assayed by restriction fragment length polymorphism. A general linear model was used to describe the relationships between HDL levels and genotypes after adjusting for age. A significant increase in HDL levels was observed after HRT (P = 0.029). Women with the ESR1 PvuII TT genotype showed a statistically significant increase in HDL levels after HRT (P = 0.032). No association was found between other ESR1 polymorphisms and HDL levels. According to our results, the ESR1 PvuII TT genotype was associated with increased levels of HDL after 1 year of HRT.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2009001200003Hormone replacement therapyHigh-density lipoprotein cholesterol levelsEstrogen receptor-alphaPolymorphism
spellingShingle N.C. Nogueira-de-Souza
I.D.C. Guerreiro da Silva
C.V. de Carvalho
A. Pulchinelli
M.A. Haidar
E.C. Baracat
A.M. Massad-Costa
Effect of estrogen receptor-alpha (ESR1) gene polymorphism on high density lipoprotein levels in response to hormone replacement therapy
Brazilian Journal of Medical and Biological Research
Hormone replacement therapy
High-density lipoprotein cholesterol levels
Estrogen receptor-alpha
Polymorphism
title Effect of estrogen receptor-alpha (ESR1) gene polymorphism on high density lipoprotein levels in response to hormone replacement therapy
title_full Effect of estrogen receptor-alpha (ESR1) gene polymorphism on high density lipoprotein levels in response to hormone replacement therapy
title_fullStr Effect of estrogen receptor-alpha (ESR1) gene polymorphism on high density lipoprotein levels in response to hormone replacement therapy
title_full_unstemmed Effect of estrogen receptor-alpha (ESR1) gene polymorphism on high density lipoprotein levels in response to hormone replacement therapy
title_short Effect of estrogen receptor-alpha (ESR1) gene polymorphism on high density lipoprotein levels in response to hormone replacement therapy
title_sort effect of estrogen receptor alpha esr1 gene polymorphism on high density lipoprotein levels in response to hormone replacement therapy
topic Hormone replacement therapy
High-density lipoprotein cholesterol levels
Estrogen receptor-alpha
Polymorphism
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2009001200003
work_keys_str_mv AT ncnogueiradesouza effectofestrogenreceptoralphaesr1genepolymorphismonhighdensitylipoproteinlevelsinresponsetohormonereplacementtherapy
AT idcguerreirodasilva effectofestrogenreceptoralphaesr1genepolymorphismonhighdensitylipoproteinlevelsinresponsetohormonereplacementtherapy
AT cvdecarvalho effectofestrogenreceptoralphaesr1genepolymorphismonhighdensitylipoproteinlevelsinresponsetohormonereplacementtherapy
AT apulchinelli effectofestrogenreceptoralphaesr1genepolymorphismonhighdensitylipoproteinlevelsinresponsetohormonereplacementtherapy
AT mahaidar effectofestrogenreceptoralphaesr1genepolymorphismonhighdensitylipoproteinlevelsinresponsetohormonereplacementtherapy
AT ecbaracat effectofestrogenreceptoralphaesr1genepolymorphismonhighdensitylipoproteinlevelsinresponsetohormonereplacementtherapy
AT ammassadcosta effectofestrogenreceptoralphaesr1genepolymorphismonhighdensitylipoproteinlevelsinresponsetohormonereplacementtherapy